General Resources

• Harvard Course on Entrepreneurship
• Nature Biotechnology's articles and Bioentrepreneur site
• Training Centers
• SBIR Information
• Kauffman eVenturing Entrepreneur's Resource Center
• A good basic outline for a Company Prospectus or First Draft Executive Summary for Investors and Entrepreneurs
• How do Investors/Entrepreneurs Evaluate Business Plans?
• Research Tools — company and industry analyses
• Other portals of entrepreneurship resources

Services for entrepreneurs:

• MIT list of services and funding resources
• High-quality assessments for CNS-related clinical trials - MedAvante
• PharmaSTART™ is a consortium of research organizations led by SRI International that offers translational drug development services to help California-based universities, research institutes, and small biotech companies bridge the gap between identifying exciting new drug discoveries and bringing them successfully through clinical development. The goal of PharmaSTART is to facilitate the translation and funding of discovery research from California based Universities and their small cap companies, by offering drug development consulting, networking, and drug development services including lead development, GLP toxicology, analytical and regulatory services and cGMP manufacturing.

Funding resources

Legal and Government Resources

Networking Tips and Tools

General advice and tips

Recommended Reading:

Booklist - http://entrepreneurship.mit.edu/booklist.php

Research on Entrepreneurship

• Hsu, David; Roberts, E.B.; Eesley, Charles. Entrepreneurs from Technology-Based Universities: Evidence from MIT. Research Policy 36 (2007) 768–788.
• Eesley, Charles E. and Roberts, Edward B., "Cutting Your Teeth: Learning from Rare Experiences" (June 2006). MIT Sloan Research Paper No. 4609-06 Available at SSRN: http://ssrn.com/abstract=909615
• Gompers, Paul A., Kovner, Anna, Lerner, Josh and Scharfstein, David S., "Skill Vs. Luck in Entrepreneurship and Venture Capital: Evidence from Serial Entrepreneurs" (October 2006). NBER Working Paper No. W12592 Available at SSRN: http://ssrn.com/abstract=937293
• Kauffman Foundation Entrepreneurship Research Portal
• M. G. Edwards, F. Murray, and R. Yu (2006). "Gold in the Ivory Tower: Equity Rewards of Outlicensing." Nature Biotechnology, Vol. 24(5), pp. 509-515.
• F. Murray (2004). "The Role of Academic Inventors in Entrepreneurial Firms: Sharing the Laboratory Life." Research Policy, Vol 33, Issue 4, pp. 643-659.
• F. Murray & L. Schiff (2004). "Biotechnology Financing Dilemmas and the Role of Special Purpose Entities." Nature Biotechnology, Vol. 22, (3) pp. 271-277.
• M. Edwards, F. Murray & R. Yu (2003)."Value Creation and Sharing Among Universities, Biotechnology and Pharma." Nature Biotechnology, Vol. 21, No. 6, pp.618-624.
• S. Kaplan, F. Murray and R. Henderson (2003). "Discontinuities and Senior Management: Assessing the Role of Recognition in Pharmaceutical Firm Response to Biotechnology." Industrial & Corporate Change, Vol. 12, No. 4, pp. 203-233.
• F. Murray (2002). "Innovation as Co-Evolution of Scientific and Technological Networks: exploring Tissue Engineering." Research Policy, Vol. 31, Issues 8-9, pp: 1389-1403.
• Hsu, David. When Does Start-up Innovation Spur the Gale of Creative Destruction? (with J. Gans and S. Stern), RAND Journal of Economics, 33: 571-586, Winter 2002.
• Hsu, David. What Do Entrepreneurs Pay for Venture Capital Affiliation?, Journal of Finance, 59: 1805-1844, August 2004.
• Hsu, David. Venture Capitalists and Cooperative Start-up Commercialization Strategy, Management Science, 52: 204-219, February 2006.
• Hsu, David. Experienced Entrepreneurial Founders, Organizational Capital, and Venture Capital Funding, Research Policy, 36: 722-741, June 2007.
• Batchelder Keith & Peter Miller. 2006. A change in the market—investing in diagnostics. Nature Biotechnology. 24(8): 922-926.